Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 50mg | $24.65 | $0.49/mg | In stock | Jul 5 |
| vial | 100mg | $33.15 | $0.33/mg | Out of stock | Jul 5 |
| vial | 50mg | $63.75 | $1.27/mg | In stock | Jul 5 |
| vial | 100mg | $84.15 | $0.84/mg | Out of stock | Jul 5 |
| vial | 50mg | $92.65 | $1.85/mg | Out of stock | Jul 5 |
| vial | 100mg | $126.65 | $1.27/mg | Out of stock |
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| CR-GCU100-2603-1 | Apr 2026 | 99.7% | BTLabs | Endotoxin | Unverified | View |
| CR-GHK100-0212-1 | Feb 2026 | 99.9% | Freedom Diagnostics | Endotoxin |
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. GHK-Cu is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Crush Research sell GHK-Cu?
Yes — Crush Research currently lists GHK-Cu in 6 variants starting at $33.15 ($0.33/mg).
Is Crush Research's GHK-Cu third-party tested?
Yes — Disclosed Labs has indexed 3 Certificates of Analysis for Crush Research's GHK-Cu, with the most recent showing 99.7% purity. Crush Research holds an overall trust grade of A (94/100) across all 105 COAs on file.
What is Crush Research's trust grade for GHK-Cu?
Crush Research has an overall Disclosed Labs trust grade of A (94/100), computed from 105 COAs across all peptides. The most recent GHK-Cu COA was issued by BTLabs.
Where is the cheapest GHK-Cu?
As of the latest data, Sunrise Bioresearch offers GHK-Cu at $0.09/mg — compare with Crush Research's listing at $0.33/mg. See the full GHK-Cu price comparison.
Is GHK-Cu legal to buy?
GHK-Cu is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| Jul 5 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
| Confirmed |
| View |
| CR-GHKC99-2511-1 | — | 99.8% | Freedom Diagnostics | Endotoxin | Confirmed | View |
Disclosed Labs